KC
ROIVW

Kepos Capital’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Kepos Capital’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-237,500
Closed -$93K – 471
2022
Q3 		$93K Hold
237,500
– – 0.01% 234
2022
Q2 		$143K Hold
237,500
– – 0.01% 235
2022
Q1 		$209K Hold
237,500
– – 0.02% 322
2021
Q4 		$486K Buy
+237,500
New +$362K 0.04% 272

Other funds holding ROIVW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return

Kepos Capital's ROIVW Position: Q4 2022 in Review

Kepos Capital sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q4 2022, closing a stake of 237,500 shares — an estimated $93K sold.

Kepos Capital first reported a position in ROIVW in Q4 2021 and held it in 4 quarters. The position peaked at $486K in Q4 2021. 28 funds tracked by Wall St. Rank hold ROIVW as of Q4 2022.

  • Kepos Capital reported no remaining Roivant Sciences Ltd. Warrant position as of Q4 2022 after selling out during the quarter.
  • Kepos Capital sold 237,500 Roivant Sciences Ltd. Warrant shares in Q4 2022, an estimated $93K.
  • Kepos Capital first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 4 quarters.
  • Kepos Capital's Roivant Sciences Ltd. Warrant position peaked at $486K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q4 2022.

Based on Kepos Capital's 13F filing for Q4 2022, filed 13 Feb 2023.